Emily S. Day

6.3k total citations · 3 hit papers
66 papers, 4.6k citations indexed

About

Emily S. Day is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Emily S. Day has authored 66 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 28 papers in Biomedical Engineering and 24 papers in Biomaterials. Recurrent topics in Emily S. Day's work include RNA Interference and Gene Delivery (29 papers), Nanoparticle-Based Drug Delivery (24 papers) and Nanoplatforms for cancer theranostics (23 papers). Emily S. Day is often cited by papers focused on RNA Interference and Gene Delivery (29 papers), Nanoparticle-Based Drug Delivery (24 papers) and Nanoplatforms for cancer theranostics (23 papers). Emily S. Day collaborates with scholars based in United States, Netherlands and France. Emily S. Day's co-authors include Rachel Riley, Jennifer L. West, Mackenzie A. Scully, Jilian R. Melamed, Rebekah A. Drezek, Nastassja A. Lewinski, Jenna C. Harris, Danielle M. Valcourt, Megan N. Dang and Lissett R. Bickford and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Genes & Development.

In The Last Decade

Emily S. Day

64 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A New Era for Cancer Treatment: Gold‐Nanoparticle‐Mediated Thermal Therapies

2010 719 citations Emily S. Day et al. Small profile →
Gold nanoparticle‐mediated photothermal therapy: applications and opportunities for multimodal cancer treatment

2017 605 citations Rachel Riley, Emily S. Day profile →
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma

2013 493 citations Emily S. Day et al. profile →

Peers

Countries citing papers authored by Emily S. Day

Since Specialization

Citations

This map shows the geographic impact of Emily S. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily S. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily S. Day more than expected).

Fields of papers citing papers by Emily S. Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily S. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily S. Day. The network helps show where Emily S. Day may publish in the future.

Co-authorship network of co-authors of Emily S. Day

This figure shows the co-authorship network connecting the top 25 collaborators of Emily S. Day. A scholar is included among the top collaborators of Emily S. Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily S. Day. Emily S. Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antibody/siRNA Nanocarriers Against Wnt Signaling Suppress Oncogenic and Stem‐Like Behavior in Triple‐Negative Breast Cancer Cells 2025 ·Journal of Biomedical Materials Research Part A ·(unknown), Emily S. Day	0
2	Influence of the protein corona on hematopoietic stem and progenitor cell uptake and macrophage clearance of membrane-wrapped nanoparticles 2025 ·Proceedings of the National Academy of Sciences ·(unknown), Lawrence Weinstein, Ashish Tiwari, (unknown), (unknown), Kejian Li, Emily S. Day	1
3	Cancer Cell Membrane-Wrapped Nanoparticles for Photothermal Therapy and Photoacoustic Imaging of Triple-Negative Breast Cancer 2025 ·ACS Applied Nano Materials ·(unknown), G. de M. Azevedo, Kejian Li, (unknown), Mackenzie A. Scully, (unknown), Emily S. Day	1
4	Conjugation of Antibodies and siRNA Duplexes to Polymer Nanoparticles via Maleimide–Thiol Chemistry 2024 ·ACS Omega ·(unknown), (unknown), (unknown), Emily S. Day	1
5	Combination cancer imaging and phototherapy mediated by membrane-wrapped nanoparticles 2023 ·International Journal of Hyperthermia ·(unknown), Mackenzie A. Scully, (unknown), Emily S. Day	5
6	E-Selectin Targeted Gold Nanoshells to Inhibit Breast Cancer Cell Binding to Lung Endothelial Cells 2023 ·ACS Applied Nano Materials ·Zeinab Fereshteh, Megan N. Dang, (unknown), Emily S. Day, John H. Slater	5
7	Delivery and short-term maternal and fetal safety of vaginally administered PEG-PLGA nanoparticles 2023 ·Drug Delivery and Translational Research ·(unknown), Katherine M. Nelson, Jason P. Gleghorn, Emily S. Day	5
8	Megakaryocyte membrane‐wrapped nanoparticles for targeted cargo delivery to hematopoietic stem and progenitor cells 2022 ·Bioengineering & Translational Medicine ·Samik Das, Jenna C. Harris, (unknown), Chen‐Yuan Kao, Emily S. Day, Eleftherios T. Papoutsakis	9
9	Membrane-wrapped nanoparticles for photothermal cancer therapy 2022 ·Nano Convergence ·(unknown), Mackenzie A. Scully, Jenna C. Harris, (unknown), Emily S. Day	43
10	Membrane-Wrapped Nanoparticles for Enhanced Chemotherapy of Acute Myeloid Leukemia 2022 ·ACS Biomaterials Science & Engineering ·Jenna C. Harris, (unknown), Emily S. Day	18
11	Membrane-wrapped nanoparticles for nucleic acid delivery 2022 ·Biomaterials Science ·Mackenzie A. Scully, (unknown), Emily S. Day	15
12	Isocorrole-Loaded Polymer Nanoparticles for Photothermal Therapy under 980 nm Light Excitation 2022 ·ACS Omega ·(unknown), (unknown), Jianxin Wang, (unknown), Glenn P. A. Yap, Emily S. Day, Joel Rosenthal	12
13	Critical Evaluation of Different Lysosomal Labeling Methods Used to Analyze RNA Nanocarrier Trafficking in Cells 2021 ·Bioconjugate Chemistry ·Shoaib Iqbal, (unknown), Jilian R. Melamed, Emily S. Day	4
14	Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer 2020 ·ACS Nano ·Danielle M. Valcourt, Megan N. Dang, Mackenzie A. Scully, Emily S. Day	65
15	Cancer Cell Membrane-Coated Nanoparticles for Cancer Management 2019 ·Cancers ·Jenna C. Harris, Mackenzie A. Scully, Emily S. Day	213
16	Gold Nanoshell-Linear Tetrapyrrole Conjugates for Near Infrared-Activated Dual Photodynamic and Photothermal Therapies 2019 ·ACS Omega ·Jianxin Wang, (unknown), Joel Rosenthal, Emily S. Day	69
17	Layer-by-Layer Assembled Gold Nanoshells for the Intracellular Delivery of miR-34a 2018 ·Cellular and Molecular Bioengineering ·Ritu Goyal, Chintan H. Kapadia, Jilian R. Melamed, Rachel Riley, Emily S. Day	32
18	Spherical Nucleic Acid Nanoparticles: Therapeutic Potential 2018 ·BioDrugs ·Chintan H. Kapadia, Jilian R. Melamed, Emily S. Day	103
19	Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods 2017 ·PLoS ONE ·Margaret M. Billingsley, Rachel Riley, Emily S. Day	51
20	Frizzled7 Antibody‐Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells 2017 ·Small ·Rachel Riley, Emily S. Day	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact